Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example

Chemistry and Physics of Lipids

Volumn 121, Issue 1-2, 2002, Pages 83-89

  Wager Miller, James ^a   Westenbroek, Ruth ^b   Mackie, Ken ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Dimerization; G protein; Receptors

Indexed keywords

AMINO ACID; CANNABINOID 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; MONOMER; OLIGOMER; POLYCLONAL ANTIBODY;

ANIMAL TISSUE; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; DIMERIZATION; GRANULE CELL; HIPPOCAMPUS; HUMAN; IMMUNOCYTOCHEMISTRY; INTERNEURON; MOLECULAR WEIGHT; MOSSY FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STAINING; WESTERN BLOTTING;

ANIMALS; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; DIMERIZATION; GTP-BINDING PROTEINS; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, CANNABINOID; RECEPTORS, CELL SURFACE; RECEPTORS, DRUG;

EID: 0037207071     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(02)00151-2     Document Type: Conference Paper

References (35)

1. Angers S., Salahpour A., et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. USA. 97:(7):2000;3684-3689.
2. Bai M., Trivedi S., et al. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J. Biol. Chem. 273:(36):1998;23605-23610.
3. Berger P., Bidart J.M., et al. Immunochemical mapping of gonadotropins. Mol. Cell. Endocrinol. 125:(1-2):1996;33-43.
4. Cvejic S., Devi L.A. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272:(43):1997;26959-26964.
5. Glass M., Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17:(14):1997;5327-5333.
6. Gomes I., Jordan B.A., et al. G protein coupled receptor dimerization: implications in modulating receptor function. J. Mol. Med. 79:(5-6):2001;226-242.
7. Gouldson P.R., Snell C.R., et al. Domain swapping in G-protein coupled receptor dimers. Protein Eng. 11:(12):1998;1181-1193.
8. Hajos N., Katona I., et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12:(9):2000;3239-3249.
9. Hart C.E., Bailey M., et al. Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry. 29:(1):1990;166-172.
10. Hebert T.E., Moffett S., et al. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271:(27):1996;16384-16392.
11. Herkenham M. Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann. New York Acad. Sci. 654:1992;19-32.
12. Hermann H., Marsicano G., et al. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience. 109:(3):2002;451-460.
13. Hoffman A.F., Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 20:(7):2000;2470-2479.
14. Howlett, A., Barth, F., et al., 2002. Classification of cannabinoid receptors. Pharmacological Reviews, in press.
15. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature. 399:(6737):1999;697-700.
16. Kroeger K.M., Hanyaloglu A.C., et al. Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. J. Biol. Chem. 276:(16):2001;12736-12743.
17. Ledent C., Valverde O., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283:(5400):1999;401-404.
18. Lee S.P., Xie Z., et al. Oligomerization of dopamine and serotonin receptors. Neuropsychopharmacology. 23:(4 Suppl.):2000;S32-S40.
19. Maggio R., Vogel Z., et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular 'cross-talk' between G-protein-linked receptors. Proc. Natl. Acad. Sci. USA. 90:(7):1993;3103-3107.
20. Meschler J.P., Clarkson F.A., et al. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates. J. Pharmacol. Exp. Ther. 292:(3):2000;952-959.
21. Milligan G. Oligomerisation of G-protein-coupled receptors. J. Cell. Sci. 114:(Pt 7):2001;1265-1271.
22. Mukhopadhyay S., McIntosh H.H., et al. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol. Pharmacol. 57:(1):2000;162-170.
23. Nava F., Carta G., et al. D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration. Br. J. Pharmacol. 130:(6):2000;1201-1210.
24. Ng G.Y., Trogadis J., et al. Agonist-induced desensitization of dopamine D1 receptor-stimulated adenylyl cyclase activity is temporally and biochemically separated from D1 receptor internalization. Proc. Natl. Acad. Sci. USA. 92:(22):1995;10157-10161.
25. Nimchinsky E.A., Hof P.R., et al. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J. Biol. Chem. 272:(46):1997;29229-29237.
26. Rocheville M., Lange D.C., et al. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 275:(11):2000;7862-7869.
27. Rodriguez J.J., Mackie K., et al. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J. Neurosci. 21:(3):2001;823-833.
28. Romano C., Yang W.L., et al. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 271:(45):1996;28612-28616.
29. Salio C., Fischer J., et al. CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport. 12:(17):2001;3689-3692.
30. Song C., Howlett A.C. Rat brain cannabinoid receptors are N-linked glycosylated proteins. Life Sci. 56:(23-24):1995;1983-1989.
31. Tsou K., Brown S., et al. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 83:(2):1998;393-411.
32. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J. Pharmacol. Exp. Ther. 262:(1):1992;10-18.
33. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 410:(6828):2001;588-592.
34. Wilson R.I., Kunos G., et al. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron. 31:(3):2001;453-462.
35. Zeng F.Y., Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274:(27):1999;19487-19497.